Nvidia Beats Expectations Again with 85 Revenue Surge But Shares Dip Amid Competition and Diversification Concerns Traders See Rising Odds of Federal Reserve Rate Hike by July 2027 Crossroads Capital Investments Bet on Nebius Group NBIS Gains Traction NPS Tier II Equity Fund Withdrawal Taxation Rules for Capital Gains Explained GitHub Outages and Rival Tools Challenge Microsofts AI Coding Ambitions French Open Prize Money Talks Progress as FFT Pledges Proposals to Players Immunocore IMCR Q1 2026 Earnings Stunning EPS Beat Masks Caution as Shares Slide 39 STGW Q1 2026 Earnings Narrow Earnings Miss Amid Solid Execution Rollins Inc ROL Q1 2026 Earnings Slight EPS Beat Amid Steady Pest Control Demand CLS Q1 2026 Earnings EPS Beat Surprises Stock Seesaws Slightly Fluent Inc Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Uncertainty SKYE Q1 2026 Earnings EPS Misses Estimates Amid No Revenue Shares Edge Higher Spring Valley Acquisition Warrants Slide 6 as SPAC Market Sentiment Weakens Nelnet NNI Edges Higher as Key Levels Come into Focus Bain Capital Specialty Finance BCSF Slips 068 Holds Near Support as Trading Volume Remains Modest Ooma Inc OOMA Advances 169 Testing Resistance at 1862 as Volume Builds SoundHound AI Warrants SOUNW Weaken Amid Broader Tech Volatility Key Support in Focus Oura and Fitbit Wearables Advance in Smart Features But Health Impact Remains Uncertain Crescent Biopharma Inc CBIO Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Kalaris Therapeutics KLRS Posts Modest Gain Holding Above Key Support